Search results - ORA - Oxford University Research Archive

1 - 7 of 7

1

Journal article

Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke

Hopewell, J, Malik, R, Valdes-Marquez, E, et al.
2017-07-17

2

Journal article

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment.

HPS2-THRIVE Collaborative Group, Jiang, L, Hopewell, J, et al.
2013-05-01

3

Journal article

The effects of vascular and nonvascular adverse events and of extended-release niacin with laropiprant on health and healthcare costs

Kent, S, Haynes, R, Hopewell, J, et al.
2016-07-12

4

Journal article

Effects of extended-release niacin with laropiprant in high-risk patients.

Landray, M, Haynes, R, Hopewell, J, et al.
2014-07-01

5

Journal article

Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study.

Hopewell, J, Parish, S, Offer, A, et al.
2013-04-01

6

Journal article

Effects of extended release niacin/laropiprant in 25,673 high-risk individuals receiving statin-based therapy: the HPS2-THRIVE randomized placebo-controlled trial

Landray, M, Haynes, R, Hopewell, J, et al.
2014-07-17

7

Journal article

Effects of anacetrapib in patients with atherosclerotic vascular disease

Bowman, L, Hopewell, J, Chen, F, et al.
2017-08-28

TO TOP